• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:MAJI)

0.0093 -0.0002 (-2.11%)
Streaming Delayed Price Updated: 3:56 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MAJI

News headline image
NexTel Medical Corp. Clarifies and Expands Upon Remarks Made During Recent Online Discussion
August 06, 2026
From NexTel Medical Corp
Via ACCESS Newswire
News headline image
NexTel Medical Corp. Executes Letter of Intent to Acquire 100% of Xycota Biosciences, LLC
August 05, 2026
From NexTel Medical Corp
Via ACCESS Newswire
News headline image
NexTel Medical Corp. Advances Veterinary Oncology Strategy with Rollout of Early-Stage Cancer Screening for Companion Animals
July 28, 2026
From NexTel Medical Corp
Via ACCESS Newswire
News headline image
Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization
December 11, 2025
Via ACCESS Newswire
News headline image
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
December 05, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Creates New Subdivisions
September 03, 2025
Via ACCESS Newswire
News headline image
Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
December 02, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value
November 17, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Announces Breakthrough In Exosome-Based Delivery
November 04, 2025
Via ACCESS Newswire
News headline image
Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA
October 28, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes
September 29, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Reports Positive Outcome in Legal Proceeding
September 26, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets
September 10, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division
September 08, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Files Reg A.
June 25, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Expands its Scientific Advisory Board
June 18, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Will Launch a Web Series with Our New Consultant
April 30, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application
April 29, 2025
Via ACCESS Newswire
News headline image
Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview
April 21, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Offers Guidance on New Subdivisions
April 17, 2025
Via ACCESS Newswire
News headline image
Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show
April 08, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Issues Update on Name Change
April 03, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Has Appointed Matthew Dwyer As Its New President
April 02, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Issues and Update on its FDA Orphan Drug Status
April 01, 2025
Via ACCESS Newswire
News headline image
Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun
March 25, 2025
Via ACCESS Newswire
News headline image
Exousia Has Successfully Renegotiated Its License Agreement
March 18, 2025
Via ACCESS Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap